Essential hypertension is a complex disease influenced by different genetic
and environmental factors. The renin-angiotensin system (RAS) is implicate
d in blood pressure regulation.
Angiotensinogen (AGT) is the precursor of the biologically active angiotens
in II (Ang II). Initial studies on hypertensive siblings and case-control s
tudies indicated the important role of the angiotensinogen gene (AGT) for t
he predisposition to essential hypertension, preeclampsia and obesity-relat
ed hypertension. Recently, different AGT poly morphisms had been identified
and analyzed in case-control studies. The aim of present studies is the an
alysis of potentially functional AGT variants (C-532T, G-6A), which might b
e responsible for the regulation of gene expression and therefore AGT gener
ation. The A-6 allele is in complete linkage disequilibrium with the T235 a
llele and is associated with higher AGT expression in vitro. Segregation li
nkage analysis demonstrated that the C-532T polymorphism influences plasma
AGT variability more significantly than the G-6A variant. Since the C-532T
polymorphism is located within a AP-2 consensus element, functional promote
r analyses are required.
The understanding of the molecular basis of RAS in essential hypertension m
ay provide us with new and more specific pharmacological agents and perhaps
the ability to individualize antihypertensive treatment.